2023
DOI: 10.1007/s00129-023-05105-w
|View full text |Cite
|
Sign up to set email alerts
|

Ectopic pregnancies: current diagnostics and treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…However, a clear predictor that can be used in place of β-hCG has not been obtained [3][4][5][6]. In addition to biomarkers, endometrial sampling can be used to diagnose EP and allows for the exclusion of intrauterine pregnancy [7]. Usually, β-hCG measurements are combined with US when diagnosing EP.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, a clear predictor that can be used in place of β-hCG has not been obtained [3][4][5][6]. In addition to biomarkers, endometrial sampling can be used to diagnose EP and allows for the exclusion of intrauterine pregnancy [7]. Usually, β-hCG measurements are combined with US when diagnosing EP.…”
Section: Introductionmentioning
confidence: 99%
“…Methotrexate (MTX), used in the medical treatment of EP and considered the gold standard, is an antitumor drug with a molecular structure similar to folic acid [5]. The antitumor mechanism of MTX involves reversible competitive action on the Dihydrofolate Reductase enzyme, leading to the impairment of purine and pyrimidine rings synthesis and resulting in the inhibition of cell division [7]. Three MTX protocols (single, double, and multiple doses) are generally accepted for treating ectopic pregnancies [10].…”
Section: Introductionmentioning
confidence: 99%